Home › Xadago (Safinamide) New Drug Application (NDA) Accepted For Filing By The U.S. Food And Drug Administration (FDA)
 

Keywords :   


Xadago (Safinamide) New Drug Application (NDA) Accepted For Filing By The U.S. Food And Drug Administration (FDA)

2015-03-04 02:40:12| drugdiscoveryonline Home Page

Newron Pharmaceuticals S.p.A. (“Newron”), a research and development company focused on novel central nervous system (CNS) and pain therapies, and its commercial and development partner, Zambon S.p.A., an international pharmaceutical company, announced recently that the New Drug Application (NDA) for Xadago (safinamide) has been accepted for filing by the U.S. Food and Drug Administration (FDA)

Tags: food application administration accepted

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
07.07Tropical Storm Beryl Forecast Discussion Number 35
07.07Tropical Storm Beryl Wind Speed Probabilities Number 35
07.07Tropical Storm Beryl Public Advisory Number 35
07.07Summary for Tropical Storm Beryl (AT2/AL022024)
07.07Tropical Storm Beryl Forecast Advisory Number 35
07.07Tropical Storm Beryl Public Advisory Number 34A
07.07Summary for Tropical Storm Beryl (AT2/AL022024)
07.07Atlantic Tropical Weather Outlook
More »